Stewart Abbot

1.5k total citations
28 papers, 1.0k citations indexed

About

Stewart Abbot is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Stewart Abbot has authored 28 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 10 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Stewart Abbot's work include CAR-T cell therapy research (6 papers), Mesenchymal stem cell research (4 papers) and Immune Cell Function and Interaction (4 papers). Stewart Abbot is often cited by papers focused on CAR-T cell therapy research (6 papers), Mesenchymal stem cell research (4 papers) and Immune Cell Function and Interaction (4 papers). Stewart Abbot collaborates with scholars based in United Kingdom, United States and Switzerland. Stewart Abbot's co-authors include David R. Blake, Clifford R. Stevens, Nicola Jordan, John Westwick, Darren A. Thompson, Kalliopi Petraki, George Kolios, Philip I. Aaronson, Arvind Kaul and Paul G. Winyard and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Stewart Abbot

27 papers receiving 1.0k citations

Peers

Stewart Abbot
Seema Dubey United States
Ying Lei China
A. Sali Australia
Dirk Pohlers Germany
Panagiotis Karagiannis United Kingdom
Seema Dubey United States
Stewart Abbot
Citations per year, relative to Stewart Abbot Stewart Abbot (= 1×) peers Seema Dubey

Countries citing papers authored by Stewart Abbot

Since Specialization
Citations

This map shows the geographic impact of Stewart Abbot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stewart Abbot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stewart Abbot more than expected).

Fields of papers citing papers by Stewart Abbot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stewart Abbot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stewart Abbot. The network helps show where Stewart Abbot may publish in the future.

Co-authorship network of co-authors of Stewart Abbot

This figure shows the co-authorship network connecting the top 25 collaborators of Stewart Abbot. A scholar is included among the top collaborators of Stewart Abbot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stewart Abbot. Stewart Abbot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Quanyuan, et al.. (2023). 900 TBio BFX 4101: a neoantigen prioritization pipeline for selected tumor-infiltrating lymphocyte therapy. SHILAP Revista de lepidopterología. A1002–A1002. 1 indexed citations
2.
Makkouk, Amani, Xue Yang, Anthony Lucas, et al.. (2021). Off-the-shelf Vδ1 gamma delta T cells engineered with glypican-3 (GPC-3)-specific chimeric antigen receptor (CAR) and soluble IL-15 display robust antitumor efficacy against hepatocellular carcinoma. Journal for ImmunoTherapy of Cancer. 9(12). e003441–e003441. 134 indexed citations
3.
Bai, Lu, Kevin Nishimoto, Mustafa Turkoz, et al.. (2020). 107 Effects of IL-2 and IL-15 on the proliferative and antitumor capacities of allogeneic CD20 CAR-engineered γδ T cells in a 3D B cell lymphoma spheroid assay. SHILAP Revista de lepidopterología. A67.1–A67.
4.
Francki, Aleksandar, Ellen Z. Baum, Stewart Abbot, et al.. (2015). Angiogenic properties of human placenta-derived adherent cells and efficacy in hindlimb ischemia. Journal of Vascular Surgery. 64(3). 746–756.e1. 22 indexed citations
5.
Liu, Wei, Xin Zhang, Xiaohua Lu, et al.. (2014). Human placenta‐derived adherent cells induce tolerogenic immune responses. Clinical & Translational Immunology. 3(5). e14–e14. 42 indexed citations
6.
Musiychuk, Konstantin, Hong Bi, R. Mark Jones, et al.. (2013). Plant-Produced Human Recombinant Erythropoietic Growth Factors Support Erythroid Differentiation In Vitro. Stem Cells and Development. 22(16). 2326–2340. 15 indexed citations
7.
Kang, Lin, Yuhong Ning, David Dong, et al.. (2013). Characterization and ex vivo Expansion of Human Placenta-Derived Natural Killer Cells for Cancer Immunotherapy. Frontiers in Immunology. 4. 101–101. 37 indexed citations
8.
Jin, Xiaoxia, Stewart Abbot, Xiaokui Zhang, et al.. (2012). Erythrocyte Enrichment in Hematopoietic Progenitor Cell Cultures Based on Magnetic Susceptibility of the Hemoglobin. PLoS ONE. 7(8). e39491–e39491. 14 indexed citations
9.
Miki, Toshio, Eva Schmelzer, Xiaokui Zhang, et al.. (2011). Compartmental Hollow Fiber Capillary Membrane–Based Bioreactor Technology for In Vitro Studies on Red Blood Cell Lineage Direction of Hematopoietic Stem Cells. Tissue Engineering Part C Methods. 18(2). 133–142. 42 indexed citations
10.
Abbot, Stewart. (2010). The Three “R”s of Blood Transfusion in 2020; Routine, Reliable and Robust. Clinics in Laboratory Medicine. 30(2). 405–417. 9 indexed citations
11.
Synnergren, Jane, Sudeshna Adak, Mikael C.O. Englund, et al.. (2008). Cardiomyogenic gene expression profiling of differentiating human embryonic stem cells. Journal of Biotechnology. 134(1-2). 162–170. 18 indexed citations
12.
Knock, Greg A., et al.. (2002). Propionate‐induced relaxation in rat mesenteric arteries: a role for endothelium‐derived hyperpolarising factor. The Journal of Physiology. 538(3). 879–890. 26 indexed citations
13.
Abbot, Stewart, et al.. (1999). Tumour necrosis factor α stimulated rheumatoid synovial microvascular endothelial cells exhibit increased shear rate dependent leucocyte adhesion in vitro. Annals of the Rheumatic Diseases. 58(9). 573–581. 18 indexed citations
14.
Jordan, Nicola, George Kolios, Stewart Abbot, et al.. (1999). Expression of functional CXCR4 chemokine receptors on human colonic epithelial cells. Journal of Clinical Investigation. 104(8). 1061–1069. 156 indexed citations
15.
Abbot, Stewart, et al.. (1998). Modulation of Arachidonic Acid Release and Membrane Fluidity by Albumin in Vascular Smooth Muscle and Endothelial Cells. Circulation Research. 83(9). 923–931. 60 indexed citations
16.
Bicknell, Roy, Ann Harris, William W. Carley, et al.. (1996). Endothelial Cell Culture. Cambridge University Press eBooks. 43 indexed citations
17.
Thorne, Sara, Stewart Abbot, Clifford R. Stevens, et al.. (1996). Modified low density lipoprotein and cytokines mediate monocyte adhesion to smooth muscle cells. Atherosclerosis. 127(2). 167–176. 40 indexed citations
18.
Collins, Peter W., Stewart Abbot, Christopher M.R. Bax, et al.. (1993). Cyclosporine And Cremaphor Modulate Von Willebrand Factor Release From Cultured Human Endothelial Cells. Transplantation. 56(5). 1218–1222. 27 indexed citations
19.
Abbot, Stewart, Arvind Kaul, Clifford R. Stevens, & David R. Blake. (1992). Isolation and culture of synovial microvascular endothelial cells. Characterization and assessment of adhesion molecule expression. Arthritis & Rheumatism. 35(4). 401–406. 64 indexed citations
20.
Stevens, Cliff R., Nadia Bucurenci, Stewart Abbot, et al.. (1992). Application of Methionine as a Detector Molecule for the Assessment of Oxygen Radical Generation by Human Neutrophils and Endothelial Cells. Free Radical Research Communications. 17(2). 143–154. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026